CLINICAL_TRIALS
trial_result
· 2024-03-25
Clinical Trial Update: A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants [Phase 2]
Summary
Phase 2 trial assessing safety, tolerability, and immunogenicity of MenABCWY vaccine in healthy infants was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Meningococcal Vaccine | Phase 2 | Status: TERMINATED | Results posted: 2024-03-25